Mpumalanga patients excited about fixed-dose ARVs
But ARV patients in the Msukaligwa Municipality weren’t always content with the HIV-treatment available to them. At one stage the Ermelo Provincial hospital was the only public health facility in the area dispensing ARVs. This meant that residents had to travel long distances to the facility, and because so many people were accessing treatment there, the queues were very long. Patients had to be at the hospital very early in the morning, even before the ARV unit opened, and still waited hours before receiving their treatment.
This situation improved drastically after the Department of Health accredited the local clinics to also dispense ARVs. ‘The accreditation of the local clinics has eased the burden on the hospital’s ARV unit,’ said a professional nurse at the Ermelo provincial hospital.
Community members are also pleased with this new arrangement as they don’t have to travel in the early hours of morning to get to the hospital. This also saves them transport money because the clinics are closer to their homes.
Since ARVs became available at the clinics treatment adherence also improved because community members had easier access to treatment.
The only problem clinics faced with this new arrangement was that some facilities had difficulty ordering treatment ‘ clinics were only receiving two of the three-drug ARV cocktail that patients had to take. But patients and clinic staff believe this problem will be solved by the new fixed combination drug that will be rolled-out in April. Instead of ordering three different drugs for every patient, they will now only have to order one.
Ntombfuthi Shongwe a counsellor at Emthonjeni clinic also said this will continue to increase treatment adherence and decrease AIDS-related deaths.
Senamile Phungula in an OurHealth Citizen Journalist reporting from the Gert Sibande health district in Mpumalanga.
Author
Health-e News is South Africa's dedicated health news service and home to OurHealth citizen journalism. Follow us on Twitter @HealtheNews
Republish this article
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Unless otherwise noted, you can republish our articles for free under a Creative Commons license. Here’s what you need to know:
You have to credit Health-e News. In the byline, we prefer “Author Name, Publication.” At the top of the text of your story, include a line that reads: “This story was originally published by Health-e News.” You must link the word “Health-e News” to the original URL of the story.
You must include all of the links from our story, including our newsletter sign up link.
If you use canonical metadata, please use the Health-e News URL. For more information about canonical metadata, click here.
You can’t edit our material, except to reflect relative changes in time, location and editorial style. (For example, “yesterday” can be changed to “last week”)
You have no rights to sell, license, syndicate, or otherwise represent yourself as the authorized owner of our material to any third parties. This means that you cannot actively publish or submit our work for syndication to third party platforms or apps like Apple News or Google News. Health-e News understands that publishers cannot fully control when certain third parties automatically summarise or crawl content from publishers’ own sites.
You can’t republish our material wholesale, or automatically; you need to select stories to be republished individually.
If you share republished stories on social media, we’d appreciate being tagged in your posts. You can find us on Twitter @HealthENews, Instagram @healthenews, and Facebook Health-e News Service.
You can grab HTML code for our stories easily. Click on the Creative Commons logo on our stories. You’ll find it with the other share buttons.
If you have any other questions, contact info@health-e.org.za.
Mpumalanga patients excited about fixed-dose ARVs
by Health-e News, Health-e News
March 29, 2013